Search details
1.
Evaluation of heroin-assisted treatment in Norway: protocol for a mixed methods study.
BMC Health Serv Res
; 24(1): 398, 2024 Mar 29.
Article
in English
| MEDLINE | ID: mdl-38553691
2.
A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS.
BMC Public Health
; 23(1): 1608, 2023 08 24.
Article
in English
| MEDLINE | ID: mdl-37612698
3.
Cause-Specific Mortality among Patients in Treatment for Opioid Use Disorder in Multiple Settings: A Prospective Comparative Cohort Study.
Eur Addict Res
; 29(4): 272-284, 2023.
Article
in English
| MEDLINE | ID: mdl-37385232
4.
Who is using take-home naloxone? An examination of supersavers.
Harm Reduct J
; 19(1): 65, 2022 06 18.
Article
in English
| MEDLINE | ID: mdl-35717240
5.
Mortality risk and causes of death among people who use opioids in a take-home naloxone cohort.
Drug Alcohol Depend
; 255: 111087, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-38228056
6.
Who receives heroin-assisted treatment? A comparison of patients receiving opioid maintenance treatment in Denmark.
Drug Alcohol Depend
; 254: 111051, 2024 Jan 01.
Article
in English
| MEDLINE | ID: mdl-38091901
7.
Pills and the damage done: the opioid epidemic as man-made crisis.
Front Public Health
; 11: 1241404, 2023.
Article
in English
| MEDLINE | ID: mdl-38283292
8.
Gender differences in physical morbidity in opioid agonist treatment patients: population-based cohort studies from the Czech Republic and Norway.
Subst Abuse Treat Prev Policy
; 18(1): 47, 2023 07 28.
Article
in English
| MEDLINE | ID: mdl-37507709
9.
Prescription high-risk polysubstance use among opioid maintenance treatment patients.
Int J Drug Policy
; : 104196, 2023 Sep 21.
Article
in English
| MEDLINE | ID: mdl-37741700
10.
Staff preferences towards electronic data collection from a national take-home naloxone program: a cross-sectional study.
Subst Abuse Treat Prev Policy
; 17(1): 13, 2022 02 16.
Article
in English
| MEDLINE | ID: mdl-35172848
11.
Risks and overdose responses: Participant characteristics from the first seven years of a national take-home naloxone program.
Drug Alcohol Depend
; 240: 109645, 2022 11 01.
Article
in English
| MEDLINE | ID: mdl-36191532
12.
A rapid assessment of take-home naloxone provision during COVID-19 in Europe.
Int J Drug Policy
; 107: 103787, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35849935
13.
Rethinking 'carriage' of take-home naloxone.
Int J Drug Policy
; 95: 103253, 2021 09.
Article
in English
| MEDLINE | ID: mdl-33848942
14.
Correction: Staff preferences towards electronic data collection from a national take-home naloxone program: a cross-sectional study.
Subst Abuse Treat Prev Policy
; 19(1): 27, 2024 May 19.
Article
in English
| MEDLINE | ID: mdl-38764080
Results
1 -
14
de 14
1
Next >
>>